0001739614-21-000117.txt : 20211207
0001739614-21-000117.hdr.sgml : 20211207
20211207194302
ACCESSION NUMBER: 0001739614-21-000117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211207
FILED AS OF DATE: 20211207
DATE AS OF CHANGE: 20211207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vuori Kristiina MD
CENTRAL INDEX KEY: 0001612627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 211477309
MAIL ADDRESS:
STREET 1: C/O WEBMD HEALTH CORP.
STREET 2: 111 EIGHTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx, Inc.
CENTRAL INDEX KEY: 0001739614
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 824257312
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wf-form4_163892416605245.xml
FORM 4
X0306
4
2021-12-07
0
0001739614
Inhibrx, Inc.
INBX
0001612627
Vuori Kristiina MD
C/O INHIBRX, INC.
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
1
0
0
0
Stock Option (right to buy)
40.45
2021-12-07
4
A
0
30000
0
A
2031-12-07
Common Stock
30000.0
30000
D
Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on December 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
/s/ Kelly D. Deck, attorney-in-fact
2021-12-07